Your browser doesn't support javascript.
loading
PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus.
Bowes, John; Loehr, Sabine; Budu-Aggrey, Ashley; Uebe, Steffen; Bruce, Ian N; Feletar, Marie; Marzo-Ortega, Helena; Helliwell, Philip; Ryan, Anthony W; Kane, David; Korendowych, Eleanor; Alenius, Gerd-Marie; Giardina, Emiliano; Packham, Jonathan; McManus, Ross; FitzGerald, Oliver; Brown, Matthew A; Behrens, Frank; Burkhardt, Harald; McHugh, Neil; Huffmeier, Ulrike; Ho, Pauline; Reis, Andre; Barton, Anne.
Afiliação
  • Bowes J; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
  • Loehr S; Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Budu-Aggrey A; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University H
  • Uebe S; Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Bruce IN; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University H
  • Feletar M; Monash University, Melbourne, Victoria, Australia.
  • Marzo-Ortega H; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.
  • Helliwell P; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.
  • Ryan AW; Department of Clinical Medicine, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland.
  • Kane D; Adelaide and Meath Hospital and Trinity College Dublin, Dublin, Ireland.
  • Korendowych E; Royal National Hospital for Rheumatic Diseases and Department Pharmacy and Pharmacology, University of Bath, Bath, UK.
  • Alenius GM; Department of Public Health and Clinical Medicine, Rheumatology, University Hospital, Umeå, Sweden.
  • Giardina E; Department of Biopathology, Centre of Excellence for Genomic Risk Assessment in Multifactorial and Complex Diseases, School of Medicine, University of Rome 'Tor Vergata' and Fondazione PTV 'Policlinico Tor Vergata', Rome, Italy.
  • Packham J; Rheumatology Department, Haywood Hospital, Health Services Research Unit, Institute of Science and Technology in Medicine, Keele University.
  • McManus R; Department of Clinical Medicine, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland.
  • FitzGerald O; Department of Rheumatology, St. Vincent's University Hospital, UCD School of Medicine and Medical Sciences and Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • Brown MA; The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland, Australia.
  • Behrens F; Division of Rheumatology and Fraunhofer IME-Project-Group Translational Medicine and Pharmacology, Goethe University, Frankfurt, Germany.
  • Burkhardt H; Division of Rheumatology and Fraunhofer IME-Project-Group Translational Medicine and Pharmacology, Goethe University, Frankfurt, Germany.
  • McHugh N; Royal National Hospital for Rheumatic Diseases and Department Pharmacy and Pharmacology, University of Bath, Bath, UK.
  • Huffmeier U; Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Ho P; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK The Kellgren Centre for Rheumatology, Central Manchester Foundation Trust, NIHR Mancheste
  • Reis A; Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Barton A; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University H
Ann Rheum Dis ; 74(10): 1882-5, 2015 Oct.
Article em En | MEDLINE | ID: mdl-25923216
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Proteína Tirosina Fosfatase não Receptora Tipo 22 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Proteína Tirosina Fosfatase não Receptora Tipo 22 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido